CD30-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA
Clinical trials for CD30-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CD30-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for CD30-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Supercharged donor cells take on stubborn lymphomas
Disease control Recruiting nowThis early-stage study tests a new approach for people with certain lymphomas (like Hodgkin lymphoma) that have come back or not responded to standard treatments. Researchers take immune cells from healthy donors, add a special receptor (C7R) to help them survive longer, and targ…
Matched conditions: CD30-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 05:49 UTC
-
Experimental T-Cell therapy targets stubborn blood cancers
Disease control Recruiting nowThis early-phase study tests a new treatment for people with certain blood cancers (like Hodgkin lymphoma) that have not responded to standard therapies. The treatment uses the patient's own immune cells, which are modified in the lab to better recognize and attack cancer cells. …
Matched conditions: CD30-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 22, 2026 13:52 UTC